Grifols is gearing up to file for approval of a drug for rare bleeding disorder acquired fibrinogen deficiency (AFD) that could provide a more reliable and easier treatment for patients.

Grifols has filed for US approval of a new drug for rare bleeding disorder acquired fibrinogen deficiency (AFD), which promises to provide a more reliable and easier treatment for patients.

25.0%; 639% avgVol] [link] announced that its affiliate, DoubleDragon [DD 9.88 ?17.2%; 214% avgVol], had acquired a 35% stake through the purchase of secondary shares from MM’s owner ...

Hypocalcemia, or low levels of calcium in the blood, can lead to calcium deficiency symptoms such as muscle aches and fatigue. To boost calcium levels, a doctor may recommend eating more calcium ...

Directed by Tom Shu-Yu Lin (“Yen and Ai-Lee” and “The Garden of Evening Mists”), the film stars Lana Condor (“To All the Boys I’ve Loved Before”), Andrew Koji (“Black Doves ...

HOUSTON, April 21, 2025 /PRNewswire/ -- Parking Guidance Systems, Inc. ("PGS") has acquired ParkZen ("ParkZen"), a parking software development company based in Baton Rouge, Louisiana. ParkZen was ...

No properties acquired by the Housing Agency have been sold on to become cost-rental tenancies, two years on from the Government scheme being introduced. The scheme was introduced following the ...

Despite India’s sunny climate, vitamin D deficiency is extremely common among Indian children. Studies have shown that more than half of Indian children and adolescents have low levels of ...

A significant portion of the White Sox future hinges on a trade made in December with the Boston Red Sox. The White Sox sent pitcher Garrett Crochet to Boston in exchange for four prospects ...

Proteomics profiling of a pre-metastatic colorectal cancer cohort identifies four proteomics-based subtypes and highlights ...

The modern lifestyle, characterised by limited sun exposure, has led to a rapid rise in vitamin D deficiency. Initially overlooked, this issue can have profound effects on the body over time.